NISA INVESTMENT ADVISORS, LLC

Position in AVIR — Atea Pharmaceuticals, Inc.

CIK 937615 ST. LOUIS, MO

Position in AVIR

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$492

-$78 QoQ

Shares Held

106

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#117

of 124 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NISA INVESTMENT ADVISORS, LLC holds $78,277,664 across 265 Biotechnology names. AVIR ranks #246 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	56,455	$28,042,892
2	REGN	Regeneron Pharmaceuticals, Inc.	19,412	$12,104,158
3	TECH	BIO-TECHNE Corp	68,452	$4,836,133
4	INCY	Incyte Corp	26,479	$3,001,659
5	ALNY	Alnylam Pharmaceuticals, Inc.	9,139	$2,751,113
6	DFTX	Definium Therapeutics, Inc.	48,369	$2,275,277
7	PRAX	Praxis Precision Medicines, Inc.	6,111	$2,045,901
8	EXEL	Exelixis, Inc.	36,758	$2,000,002

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$492	106	0.0%	Shares	Sole	2026-08-10
2026-03-31	$570	106	0.0%	Shares	Sole	2026-04-30
2025-12-31	$378	106	0.0%	Shares	Sole	2026-01-15
2025-09-30	$307	106	0.0%	Shares	Sole	2025-10-23
2025-06-30	$381	106	-62.3%	Shares	Sole	2025-07-31
2025-03-31	$840	281	+1121.7%	Shares	Sole	2025-04-30
2024-12-31	$77	23	-82.0%	Shares	Sole	2025-01-17
2024-09-30	$428	128	-29.7%	Shares	Sole	2024-10-24
2024-06-30	$602	182	+691.3%	Shares	Sole	2024-07-19
2024-03-31	$92	23	0.0%	Shares	Sole	2024-05-02
2023-12-31	$70	23	-99.7%	Shares	Sole	2024-01-25
2023-09-30	$20,001	6,667	+22.4%	Shares	Sole	2023-11-02
2023-06-30	$20,371	5,447	+4439.2%	Shares	Sole	2023-08-11
2022-12-31	$1	120	—	Shares	Sole	2023-02-02
No filing history on record for this holder in this stock.